How does Medicamen Organics Ltd (NSE: MEDIORG.NS) compare with companies in other sectors?

MEDIORG.NS on the NSE trades at a P/E of N/A with a net margin of 0.00% and ROE of 0.00%, which positions it against peers in the Healthcare sector and beyond.

What are MEDIORG.NS's (NSE) net and operating margins?

On the NSE, MEDIORG.NS reports a net profit margin of 0.00% and an operating margin of 0.00%.

In what way does MEDIORG.NS's (NSE) EPS trend reflect its financial momentum?

MEDIORG.NS's EPS growth on the NSE is 0.00% and its 5-year EPS CAGR is 0.00%, indicating its earnings momentum.

What does MEDIORG.NS's (NSE) ROE tell investors?

MEDIORG.NS on the NSE posts an ROE of 0.00%, showing how much profit Medicamen Organics Ltd generates for every $100 of shareholder equity.

How do I know if MEDIORG.NS (NSE) is overvalued or undervalued?

MEDIORG.NS on the NSE trades at a P/E of N/A and a PEG of N/A; compared with the P/E benchmark of 32.02, this suggests valuation should be reviewed against sector peers.

Medicamen Organics Ltd Fundamental Analysis (NSE: MEDIORG.NS)

MEDIORG.NS●NSE

HealthcareMedical - Pharmaceuticals

₹23.15

₹1.15(4.73%)

Indian Market opens in 5h 36m

Medicamen Organics Ltd Fundamental Analysis (NSE: MEDIORG.NS)

Medicamen Organics Ltd (NSE: MEDIORG.NS) shows weak financial fundamentals with a PE ratio of -6.79, profit margin of N/A, and ROE of N/A. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

No significant strengths identified.

Areas of Concern

No major concerns flagged.

We analyze MEDIORG.NS's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 0.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

0.0/100

We analyze MEDIORG.NS's fundamental strength across five key dimensions:

Efficiency Score

Weak

MEDIORG.NS struggles to generate sufficient returns from assets.

ROA > 10%

N/A

Valuation Score

Moderate

MEDIORG.NS shows balanced valuation metrics.

PE < 25

-6.79

PEG Ratio < 2

N/A

Growth Score

Weak

MEDIORG.NS faces weak or negative growth trends.

Revenue Growth > 5%

N/A

EPS Growth > 10%

N/A

Financial Health Score

Weak

MEDIORG.NS carries high financial risk with limited liquidity.

Debt/Equity < 1

N/A

Current Ratio > 1

N/A

Profitability Score

Weak

MEDIORG.NS struggles to sustain strong margins.

ROE > 15%

N/A

Net Margin ≥ 15%

N/A

Positive Free Cash Flow

N/A

Key Financial Metrics

Is MEDIORG.NS Expensive or Cheap?

P/E Ratio

MEDIORG.NS trades at -6.79 times earnings. This suggests potential undervaluation.

-6.79

How Well Does MEDIORG.NS Make Money?

No data available.

Following the Money - Real Cash Generation

No data available.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

N/A

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

N/A

vs 25 benchmark

P/B Ratio

Price to book value ratio

N/A

vs 25 benchmark

P/S Ratio

Price to sales ratio

N/A

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

N/A

vs 25 benchmark

Current Ratio

Current assets to current liabilities

N/A

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

N/A

vs 25 benchmark

ROA

Return on assets percentage

N/A

vs 25 benchmark

ROCE

Return on capital employed

N/A

vs 25 benchmark

How MEDIORG.NS Stacks Against Its Sector Peers

Metric	MEDIORG.NS Value	Sector Average	Performance
P/E Ratio	N/A	32.02	N/A
ROE	N/A	569.00%	N/A
Net Margin	N/A	29948.00%	N/A
Debt/Equity	N/A	0.53	N/A
Current Ratio	N/A	5.67	N/A
ROA	N/A	-98.00% (disorted)	N/A

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Medicamen Organics Ltd's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Medicamen Organics Ltd Fundamental Analysis (NSE: MEDIORG.NS)

Key Strengths

Areas of Concern

Fundamental Health Score

Efficiency Score

Valuation Score

Growth Score

Financial Health Score

Profitability Score

Key Financial Metrics

Is MEDIORG.NS Expensive or Cheap?

How Well Does MEDIORG.NS Make Money?

Following the Money - Real Cash Generation

Financial Ratios Analysis

Valuation Ratios

Financial Health

Efficiency Ratios

How MEDIORG.NS Stacks Against Its Sector Peers

Historical Growth Performance

5-Year Growth Trajectory

Fundamental Analysis FAQ

How does Medicamen Organics Ltd (NSE: MEDIORG.NS) compare with companies in other sectors?

What are MEDIORG.NS's (NSE) net and operating margins?

In what way does MEDIORG.NS's (NSE) EPS trend reflect its financial momentum?

What does MEDIORG.NS's (NSE) ROE tell investors?

How do I know if MEDIORG.NS (NSE) is overvalued or undervalued?